FDA Person
FDAGabrielle J. Swain
View detailed information about Gabrielle J. Swain, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Gabrielle J. Swain, including their role, qualifications, and regulatory activities.
Recent Records (15)
483 - Vincent DiGiovanni, DO
483
483 - Hummayun Ismail, M.D.
483
483 - Gautam T. Jayram, M.D.
483
483 - DERMDOX CENTERS FOR DERMATOLOGY
483
483 - Charles River Laboratories Inc.
483
483 - Wills Eye Hospital IRB
483
483 - Gene Logic, Inc.
483
483 - Enrico Bertini MD
483
EIR - Pfizer, Inc.
EIR
EIR - Janssen Biotech Inc.
EIR
483 - Acrotech Biopharma Inc.
483
483 - Adam Peyton, D.O.
483
483 - Enrico Bertini MD
483
483 - Charles River Laboratories Inc.
483
483 - Cooper Health System IRB
483
Person Information
Name
Gabrielle J. Swain
Title
investigator
Role
COMPANY REP
ID: 55f33430-41dc-4fae-bac0-ec6ea340feb6
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.